HighTower Advisors’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $144K | Buy |
+11,198
| New | +$143K | ﹤0.01% | 3572 |
|
|
2025
Q4 | – | Sell |
-36,986
| Closed | -$639K | – | 3871 |
|
|
2025
Q3 | $639K | Buy |
36,986
+20,367
| +123% | +$251K | ﹤0.01% | 2424 |
|
|
2025
Q2 | $156K | Sell |
16,619
-302
| -2% | -$2.48K | ﹤0.01% | 3376 |
|
|
2025
Q1 | $120K | Buy |
16,921
+1,282
| +8% | +$12.9K | ﹤0.01% | 3328 |
|
|
2024
Q4 | $182K | Sell |
15,639
-4,639
| -23% | -$72.4K | ﹤0.01% | 3227 |
|
|
2024
Q3 | $415K | Sell |
20,278
-2,967
| -13% | -$68.4K | ﹤0.01% | 2543 |
|
|
2024
Q2 | $515K | Sell |
23,245
-113
| -0.5% | -$2.69K | ﹤0.01% | 2297 |
|
|
2024
Q1 | $642K | Sell |
23,358
-439
| -2% | -$12.2K | ﹤0.01% | 2098 |
|
|
2023
Q4 | $724K | Sell |
23,797
-1,782
| -7% | -$51.2K | ﹤0.01% | 2036 |
|
|
2023
Q3 | $808K | Sell |
25,579
-2,360
| -8% | -$91.6K | ﹤0.01% | 1915 |
|
|
2023
Q2 | $1.14M | Sell |
27,939
-427
| -2% | -$17.3K | ﹤0.01% | 1681 |
|
|
2023
Q1 | $1.06M | Buy |
28,366
+2,279
| +9% | +$89.4K | ﹤0.01% | 1638 |
|
|
2022
Q4 | $910K | Sell |
26,087
-1,708
| -6% | -$81.2K | ﹤0.01% | 1735 |
|
|
2022
Q3 | $1.55M | Buy |
27,795
+112
| +0.4% | +$6.95K | ﹤0.01% | 1384 |
|
|
2022
Q2 | $1.44M | Sell |
27,683
-5,429
| -16% | -$276K | ﹤0.01% | 1440 |
|
|
2022
Q1 | $2.41M | Sell |
33,112
-3,945
| -11% | -$334K | 0.01% | 1262 |
|
|
2021
Q4 | $4.38M | Buy |
37,057
+4,873
| +15% | +$610K | 0.01% | 974 |
|
|
2021
Q3 | $4.32M | Buy |
32,184
+3,660
| +13% | +$554K | 0.01% | 888 |
|
|
2021
Q2 | $4.62M | Sell |
28,524
-6,332
| -18% | -$493K | 0.01% | 831 |
|
|
2021
Q1 | $2.8M | Buy |
34,856
+5,304
| +18% | +$356K | 0.01% | 969 |
|
|
2020
Q4 | $1.6M | Sell |
29,552
-8,552
| -22% | -$311K | 0.01% | 1004 |
|
|
2020
Q3 | $756K | Buy |
38,104
+23,204
| +156% | +$484K | ﹤0.01% | 1362 |
|
|
2020
Q2 | $314K | Buy |
14,900
+1,125
| +8% | +$19.1K | ﹤0.01% | 1709 |
|
|
2020
Q1 | $168K | Sell |
13,775
-1,308
| -9% | -$17.6K | ﹤0.01% | 1838 |
|
|
2019
Q4 | $219K | Sell |
15,083
-2,242
| -13% | -$31.2K | ﹤0.01% | 1912 |
|
|
2019
Q3 | $231K | Sell |
17,325
-19,112
| -52% | -$305K | ﹤0.01% | 1970 |
|
|
2019
Q2 | $598K | Buy |
36,437
+1,826
| +5% | +$28.7K | ﹤0.01% | 1425 |
|
|
2019
Q1 | $594K | Buy |
34,611
+19,885
| +135% | +$296K | ﹤0.01% | 1370 |
|
|
2018
Q4 | $201K | Buy |
14,726
+2,115
| +17% | +$39.3K | ﹤0.01% | 1840 |
|
|
2018
Q3 | $360K | Buy |
12,611
+4,345
| +53% | +$126K | ﹤0.01% | 1633 |
|
|
2018
Q2 | $226K | Buy |
+8,266
| New | +$200K | ﹤0.01% | 1841 |
|
|
2018
Q1 | – | Sell |
-15,200
| Closed | -$293K | – | 2289 |
|
|
2017
Q4 | $293K | Buy |
+15,200
| New | +$351K | ﹤0.01% | 1721 |
|
Other funds holding NTLA
AIM
VPM
VCM
RP
